[Federal Register Volume 62, Number 40 (Friday, February 28, 1997)]
[Notices]
[Pages 9197-9198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-4960]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. 96E-0080]


Determination of Regulatory Review Period for Purposes of Patent 
Extension; Olean; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of January 6, 1997 (62 FR 763).

[[Page 9198]]

The document announced FDA's determination of the regulatory review 
period for purposes of patent extension for Olean (olestra). The 
document was published with an error. This document corrects that 
error.

FOR FURTHER INFORMATION CONTACT: Brian J. Malkin, Office of Health 
Affairs (HFY-20), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-443-1382.

    In FR Doc. 97-138, appearing on page 763 in the Federal Register of 
Monday, January 6, 1997, the following correction is made: On page 763, 
in the third column, beginning in line 6, ``Olean (U.S. Patent No. 
4,005,196)'' is corrected to read ``Olean (U.S. Patent No. Re. 
34,617)''.

    Dated: February 20, 1997.
Allen B. Duncan,
Acting Associate Commissioner for Health Affairs.
[FR Doc. 97-4960 Filed 2-27-97; 8:45 am]
BILLING CODE 4160-01-F